XML 48 R37.htm IDEA: XBRL DOCUMENT
v3.21.2

SHAREHOLDERS' EQUITY (Narrative) (Details) |  |  |  | 1 Months Ended | 9 Months Ended | 12 Months Ended
--- | --- | --- | --- | --- | --- | ---
Feb. 22, 2021 USD ($) $ / shares shares | Jul. 31, 2020 USD ($) $ / shares shares | Aug. 27, 2019 USD ($) $ / shares shares | Jan. 31, 2016 $ / shares shares | Jun. 30, 2021 USD ($) $ / shares shares | Jun. 30, 2020 USD ($) $ / shares shares | Sep. 30, 2020 shares
SHAREHOLDERS' EQUITY |  |  |  |  |  |  |
Aggregate gross proceeds | $ |  |  |  |  | $ 149,999,985 | $ 0 |
Share issuance transaction costs | $ |  |  |  |  | $ 9,229,451 | $ 314,603 |
Options granted |  |  |  |  | 1,889,646 | 4,218,000 | 4,218,000
Weighted average fair value of options granted | $ / shares |  |  |  |  | $ 9.87 | $ 3.31 |
Employee Share Purchase Plan [Member] |  |  |  |  |  |  |
SHAREHOLDERS' EQUITY |  |  |  |  |  |  |
Number of new stock issued during the period upon the exercise of Purchase Rights |  |  |  |  | 10,702 | 16,506 |
Offering term |  |  |  |  | 9 months |  |
Maximum eligibility to common shares amount | $ |  |  |  |  | $ 25,000 |  |
Stock Options [Member] |  |  |  |  |  |  |
SHAREHOLDERS' EQUITY |  |  |  |  |  |  |
Option expiration period |  |  |  |  | 10 years |  |
RSU's [Member] |  |  |  |  |  |  |
SHAREHOLDERS' EQUITY |  |  |  |  |  |  |
RSUs outstanding |  |  |  |  | 0 |  |
Minimum [Member] | Employee Share Purchase Plan [Member] |  |  |  |  |  |  |
SHAREHOLDERS' EQUITY |  |  |  |  |  |  |
Price percentage of common share granted |  |  |  |  | 85.00% |  |
Maximum [Member] | Employee Share Purchase Plan [Member] |  |  |  |  |  |  |
SHAREHOLDERS' EQUITY |  |  |  |  |  |  |
Common shares reserved for issuance |  |  |  |  | 252,418 | 284,887 |
Employee contribution percentage |  |  |  |  | 15.00% |  |
Maximum [Member] | Stock Options and RSU Plan [Member] |  |  |  |  |  |  |
SHAREHOLDERS' EQUITY |  |  |  |  |  |  |
Common shares reserved for issuance |  |  |  |  | 7,342,788 |  |
February 2021 Financing [Member] |  |  |  |  |  |  |
SHAREHOLDERS' EQUITY |  |  |  |  |  |  |
Aggregate gross proceeds | $ | $ 149,999,985 |  |  |  |  |  |
Shares issued | 5,555,555 |  |  |  |  |  |
Offering price per share | $ / shares | $ 27.00 |  |  |  |  |  |
Underwriter option to purchase additional securities | 724,637 |  |  |  |  |  |
Term of underwriters option | 30 days |  |  |  |  |  |
Cash commissions paid | $ | $ 8,999,999 |  |  |  |  |  |
Share issuance transaction costs | $ | $ 229,451 |  |  |  |  |  |
July 2020 Financing [Member] |  |  |  |  |  |  |
SHAREHOLDERS' EQUITY |  |  |  |  |  |  |
Aggregate gross proceeds | $ |  | $ 48,990,000 |  |  |  |  |
Shares issued |  | 7,100,000 |  |  |  |  |
Offering price per share | $ / shares |  | $ 6.00 |  |  |  |  |
Underwriter option to purchase additional securities |  | 1,065,000 |  |  |  |  |
Term of underwriters option |  | 30 days |  |  |  |  |
Cash commissions paid | $ |  | $ 2,939,400 |  |  |  |  |
Share issuance transaction costs | $ |  | $ 212,256 |  |  |  |  |
August 2019 Financing [Member] |  |  |  |  |  |  |
SHAREHOLDERS' EQUITY |  |  |  |  |  |  |
Aggregate gross proceeds | $ |  |  | $ 36,000,000 |  |  |  |
Shares issued |  |  | 6,080,596 |  |  |  |
Offering price per share | $ / shares |  |  | $ 2.00 |  |  |  |
Number of pre funded warrants issued |  |  | 11,919,404 |  |  |  |
Conversion of each prefunded warrant into common share |  |  | 1 |  |  |  |
Term of warrant |  |  | 5 years |  |  |  |
Cash commissions paid | $ |  |  | $ 1,978,770 |  |  |  |
Share issuance transaction costs | $ |  |  | $ 698,162 |  |  |  |
Private Placement [Member] |  |  |  |  |  |  |
SHAREHOLDERS' EQUITY |  |  |  |  |  |  |
Shares issued |  |  |  | 227,273 |  |  |
Offering price per share | $ / shares |  |  |  | $ 66.00 |  |  |
Number of Units issued |  |  |  | 227,273 |  |  |
Units issued in private placement, conversion ratio |  |  |  | 1 |  |  |
Private Placement [Member] | 2 Year Warrants [Member] |  |  |  |  |  |  |
SHAREHOLDERS' EQUITY |  |  |  |  |  |  |
Term of warrant |  |  |  | 2 years |  |  |
Units issued in private placement, conversion ratio |  |  |  | 0.5 |  |  |
Private Placement [Member] | 7 Year Warrants [Member] |  |  |  |  |  |  |
SHAREHOLDERS' EQUITY |  |  |  |  |  |  |
Term of warrant |  |  |  | 7 years |  |  |
Units issued in private placement, conversion ratio |  |  |  | 1 |  |  |
Private Placement [Member] | Clarus Lifesciences III, L.P [Member] |  |  |  |  |  |  |
SHAREHOLDERS' EQUITY |  |  |  |  |  |  |
Number of shares acquired by shareholders |  |  |  | 106,061 |  |  |
Minimum number of shares required to be held for nomination rights |  |  |  | 53,030 |  |  |

X
- Definition Percentage of contribution by each employee to employee share purchase plan. + References No definition available. + Details
Name: | epix_ContributionPerEmployeeToEmployeeSharePurchasePlanPercentage
Namespace Prefix: | epix_
Data Type: | num:percentItemType
Balance Type: | na
Period Type: | duration

X
- Definition Maximum amount of common share each employee is eligible under employee share purchase plan. + References No definition available. + Details
Name: | epix_MaximumEligibleCommonSharesUnderEmployeeSharePurchasePlan
Namespace Prefix: | epix_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition Minimum number of shares required to be held for nomination rights + References No definition available. + Details
Name: | epix_MinimumNumberOfSharesRequiredToBeHeldForNominationRights
Namespace Prefix: | epix_
Data Type: | xbrli:sharesItemType
Balance Type: | na
Period Type: | duration

X
- Definition Number of new stock issued during the period upon the exercise of Purchase Rights. + References No definition available. + Details
Name: | epix_NumberOfNewStockIssuedDuringPeriodUponExerciseOfPurchaseRights
Namespace Prefix: | epix_
Data Type: | xbrli:sharesItemType
Balance Type: | na
Period Type: | duration

X
- Definition Number of shares acquired by shareholders. + References No definition available. + Details
Name: | epix_NumberOfSharesAcquiredByShareholders
Namespace Prefix: | epix_
Data Type: | xbrli:sharesItemType
Balance Type: | na
Period Type: | duration

X
- Definition Number of Units, consisting of common share and warrants issued. + References No definition available. + Details
Name: | epix_NumberOfUnitsIssued
Namespace Prefix: | epix_
Data Type: | xbrli:sharesItemType
Balance Type: | na
Period Type: | duration

X
- Definition Number of pre funded warrants issued. + References No definition available. + Details
Name: | epix_PreFundedWarrantsIssuedForCommonShares
Namespace Prefix: | epix_
Data Type: | xbrli:sharesItemType
Balance Type: | na
Period Type: | duration

X
- Definition Term of purchase rights offering. + References No definition available. + Details
Name: | epix_PurchaseRightsOfferingTerm
Namespace Prefix: | epix_
Data Type: | xbrli:durationItemType
Balance Type: | na
Period Type: | duration

X
- Definition Term of underwriters option to purchase additions shares. + References No definition available. + Details
Name: | epix_TermOfUnderwritersOption
Namespace Prefix: | epix_
Data Type: | xbrli:durationItemType
Balance Type: | na
Period Type: | duration

X
- Definition Underwriter option to purchase additional securities. + References No definition available. + Details
Name: | epix_UnderwriterOptionToPurchaseAdditionalSecurities
Namespace Prefix: | epix_
Data Type: | xbrli:sharesItemType
Balance Type: | na
Period Type: | duration

X
- Definition Units issued in private placement, conversion ratio + References No definition available. + Details
Name: | epix_UnitsIssuedInPrivatePlacementConversionRatio
Namespace Prefix: | epix_
Data Type: | xbrli:pureItemType
Balance Type: | na
Period Type: | duration

X
- Definition Number of securities into which each warrant or right may be converted. For example, but not limited to, each warrant may be converted into two shares. + References No definition available. + Details
Name: | us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight
Namespace Prefix: | us-gaap_
Data Type: | xbrli:sharesItemType
Balance Type: | na
Period Type: | instant

X
- Definition Aggregate number of common shares reserved for future issuance. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02.29) -URI http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682 + Details
Name: | us-gaap_CommonStockCapitalSharesReservedForFutureIssuance
Namespace Prefix: | us-gaap_
Data Type: | xbrli:sharesItemType
Balance Type: | na
Period Type: | instant

X
- Definition The amount of cash paid for commissions during the current period. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 45 -Paragraph 25 -Subparagraph (g) -URI http://asc.fasb.org/extlink&oid=121586364&loc=d3e3536-108585 + Details
Name: | us-gaap_PaymentsForCommissions
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition The cash outflow for cost incurred directly with the issuance of an equity security. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 45 -Paragraph 15 -URI http://asc.fasb.org/extlink&oid=121586364&loc=d3e3291-108585 + Details
Name: | us-gaap_PaymentsOfStockIssuanceCosts
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition The cash inflow from the additional capital contribution to the entity. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 45 -Paragraph 14 -Subparagraph (a) -URI http://asc.fasb.org/extlink&oid=121586364&loc=d3e3255-108585 + Details
Name: | us-gaap_ProceedsFromIssuanceOfCommonStock
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (c)(2)(i)-(ii) -URI http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901 + Details
Name: | us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
Namespace Prefix: | us-gaap_
Data Type: | xbrli:sharesItemType
Balance Type: | na
Period Type: | instant

X
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. + References No definition available. + Details
Name: | us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Gross number of share options (or share units) granted during the period. + References No definition available. + Details
Name: | us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
Namespace Prefix: | us-gaap_
Data Type: | xbrli:sharesItemType
Balance Type: | na
Period Type: | duration

X
- Definition The weighted average grant-date fair value of options granted during the reporting period as calculated by applying the disclosed option pricing methodology. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (d)(1) -URI http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901 + Details
Name: | us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
Namespace Prefix: | us-gaap_
Data Type: | num:perShareItemType
Balance Type: | na
Period Type: | duration

X
- Definition Period from grant date that an equity-based award expires, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (a)(2) -URI http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901 + Details
Name: | us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod
Namespace Prefix: | us-gaap_
Data Type: | xbrli:durationItemType
Balance Type: | na
Period Type: | duration

X
- Definition Purchase price of common stock expressed as a percentage of its fair value. + References No definition available. + Details
Name: | us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent
Namespace Prefix: | us-gaap_
Data Type: | num:percentItemType
Balance Type: | na
Period Type: | duration

X
- Definition Per share or per unit amount of equity securities issued. + References No definition available. + Details
Name: | us-gaap_SharesIssuedPricePerShare
Namespace Prefix: | us-gaap_
Data Type: | num:perShareItemType
Balance Type: | na
Period Type: | instant

X
- Definition Number of new stock issued during the period. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02(29)) -URI http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 505 -SubTopic 10 -Section 50 -Paragraph 2 -URI http://asc.fasb.org/extlink&oid=109259400&loc=d3e21463-112644 Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 505 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.3-04) -URI http://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770 Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02(28)) -URI http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682 + Details
Name: | us-gaap_StockIssuedDuringPeriodSharesNewIssues
Namespace Prefix: | us-gaap_
Data Type: | xbrli:sharesItemType
Balance Type: | na
Period Type: | duration

X
- Definition Period between issuance and expiration of outstanding warrant and right embodying unconditional obligation requiring redemption by transferring asset at specified or determinable date or upon event certain to occur, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Publisher FASB -Name Accounting Standards Codification -Topic 820 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (bbb)(2) -URI http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258 + Details
Name: | us-gaap_WarrantsAndRightsOutstandingTerm
Namespace Prefix: | us-gaap_
Data Type: | xbrli:durationItemType
Balance Type: | na
Period Type: | instant

X
- Details
Name: | us-gaap_PlanNameAxis=epix_EmployeeSharePurchasePlanMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_AwardTypeAxis=us-gaap_EmployeeStockMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_RangeAxis=srt_MinimumMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_RangeAxis=srt_MaximumMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_AwardTypeAxis=epix_StockOptionsAndRsuPlanMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_SubsidiarySaleOfStockAxis=epix_February2021financingMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_SubsidiarySaleOfStockAxis=epix_July2020FinancingMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_SubsidiarySaleOfStockAxis=epix_August2019FinancingMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_SubsidiarySaleOfStockAxis=us-gaap_PrivatePlacementMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_ClassOfWarrantOrRightAxis=epix_TwoYearWarrantMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_ClassOfWarrantOrRightAxis=epix_SevenYearWarrantMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | dei_LegalEntityAxis=epix_ClarusLifesciencesIiiL.pMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |